Nuvation Bio (NUVB)
NYSE:NUVB
US Market

Nuvation Bio (NUVB) Stock Price & Analysis

65 Followers

NUVB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.59 - $6.05
Previous Close$2.4
Volume275.23K
Average Volume (3M)862.94K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$673.95M
Total Debt (Recent Filing)$4.47M
Price to Earnings (P/E)-4.8
Beta0.68
Next EarningsMar 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-0.50
Shares Outstanding218,392,607
R-Squared0.05
Standard Deviation0.15
10 Day Avg. Volume427,536
30 Day Avg. Volume862,940
Price to Book (P/B)0.80
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-6.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside35.42% Upside
Rating ConsensusModerate Buy
Alpha-0.04
Number of Analyst Covering2


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

NUVB FAQ

What was Nuvation Bio’s price range in the past 12 months?
Nuvation Bio lowest stock price was $1.59 and its highest was $6.05 in the past 12 months.
    What is Nuvation Bio’s market cap?
    Currently, no data Available
    When is Nuvation Bio’s upcoming earnings report date?
    Nuvation Bio’s upcoming earnings report date is Mar 09, 2023 which is in 30 days.
      How were Nuvation Bio’s earnings last quarter?
      Nuvation Bio released its earnings results on Nov 03, 2022. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.14 by $0.02.
        Is Nuvation Bio overvalued?
        According to Wall Street analysts Nuvation Bio’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Nuvation Bio pay dividends?
          Nuvation Bio does not currently pay dividends.
          What is Nuvation Bio’s EPS estimate?
          Nuvation Bio’s EPS estimate is -$0.12.
            How many shares outstanding does Nuvation Bio have?
            Nuvation Bio has 217,392,610 shares outstanding.
              What happened to Nuvation Bio’s price movement after its last earnings report?
              Nuvation Bio reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.14. Following the earnings report the stock price went down -2.336%.
                Which hedge fund is a major shareholder of Nuvation Bio?
                Among the largest hedge funds holding Nuvation Bio’s share is Omega Fund Management, LLC. It holds Nuvation Bio’s shares valued at 34M.

                  ---

                  Nuvation Bio Stock Smart Score

                  3
                  Underperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -57.82%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -15.10%
                  Trailing 12-Months
                  Asset Growth
                  -13.95%
                  Trailing 12-Months
                  The Nuvation Bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Nuvation Bio

                  Panacea Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Evolus
                  Phathom Pharmaceuticals
                  Tarsus Pharmaceuticals
                  Rani Therapeutics Holdings

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis